Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Johnson & Johnson Announces Dividend Increase of 10.8%

    NEW BRUNSWICK, N.J., April 24 /PRNewswire-FirstCall/ -- Johnson &
Johnson today announced that its Board of Directors has declared a 10.8%
increase in the quarterly dividend rate, from $.415 per share to $.46 per
share. The increase was announced this morning at the Annual Shareholders
Meeting in New Brunswick, NJ.

    "In recognition of our solid results in 2007, our strong financial
position, and our confidence in the future of Johnson & Johnson, the Board
has voted to increase the dividend for the 46th consecutive year," said
William C. Weldon, Chairman and Chief Executive Officer of the Company.

    At the new rate, the indicated dividend on an annual basis is $1.84 per
share compared to the previous rate of $1.66 per share. The next quarterly
dividend is payable on June 10, 2008 to shareholders of record as of May
27, 2008.

    About Johnson & Johnson

    Caring for the world, one person at a time ... inspires and unites the
people of Johnson & Johnson. We embrace research and science -- bringing
innovative ideas, products and services to advance the health and
well-being of people. Our 119,500 employees at more than 250 Johnson &
Johnson companies work with partners in health care to touch the lives of
over a billion people every day, throughout the world.



SOURCE Johnson & Johnson




Back to Topback to top

Related links:
  • http://www.jnj.com
  • http://www.prnewswire.com/comp/467347.html /
    CONTACT:
    Media: Jeffrey J. Leebaw, +1-732-524-3350, or
    +1-732-642-6608, mobile, or Bill Price, +1-732-524-6623, or
    +1-732-668-3735, mobile; or Investors: Louise Mehrotra,
    +1-732-524-6491, or Stan Panasewicz, +1-732-524-2524, or Lesley
    Fishman, +1-732-524-3922, or Tina Pinto, +1-732-524-2034, all of
    Johnson & Johnson